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Summary
The role of CD4+ and CD8+ T cells in mediating pulmonary clearance of a cryptococcal
infection was investigated. Intratracheal inoculation ofBALB/c and C.B-17 mice with a moderately
virulent strain of Cryptococcus neoformans (52D) resulted in a pulmonary infection, which was
cleared by a T cell-dependent mechanism. During this clearance, there was a significant influx
of both CD4+ and CD8+ T cells into the lungs. Depletion of CD4+ T cells by injections of
CD4-specific monoclonal antibody (mAb) prevented pulmonary clearance and also resulted in
significant colonization of the brain and spleen ofinfected mice. CD4 depletion did not prevent
the influx of CD8+ T cells into the lungs. Surprisingly, depletion of CD8+ T cells by mAb
also ablated pulmonary clearance. CD8-depleted mice also had a small but significant increase
in brain and spleen colony-forming unit compared to control mice by the end of the study.
CD4+ T cell pulmonary influx was independent of the presence of CD8+ T cells. The lungs
of T cell-depleted mice were examined histologically. CD4+ and CD8+ T cells each mediated
a degree of inflammatory influx seen in the lungs of infected mice and raised the possibility
that CD4+ and CD8+ T cells may synergize to generate the inflammatory response in the lungs.
Numerous phagocytized but intact cryptococci were seen in the inflammatory foci of CD8-depleted
mice but not in control or CD4-depleted mice. We propose that CD4+ T cells may recruit
and activate effector phagocytes while CD8+ T cells predominantly function to lyse crypto-
coccus-laden unactivated phagocytes similar to the function of CD8+ T cells during listeria and
mycobacteria infections.
T
cell-mediated immunity (CMI)l is a critical compo-
nent ofprotective immunity against infection by theyeast
Cryptococcus neoformans (1). Both CD4+ (also known as
L3T4+ or Lyt-1+2- in the mouse) and CD8+ (murine Lyt-
1 - 2+) T cells are involved in the systemic anticryptococcal
immune response (1). CD4+ T cells mediate anticrypto-
coccal delayed type hypersensitivity (DTH) (2-5), the devel-
opment of Ts (6-8), and clearance of extrapulmonary infec-
tion (5). CD8+ T cells, in contrast, may downregulate the
systemic anticryptococcal immune response through the de-
velopment of Ts, which can suppress T cell responses (2, 7,
9, 10) and phagocytosis (11-13).
The lungs are the portal of entry for the infectious agent
of cryptococcosis and would be the initial site for the devel-
opment of anticryptococcal CMI. The role of CD4+ and
CD8+ T cells in pulmonary clearance is uncertain. Indeed,
Abbreviations used in this paper: CMI, T cell-mediated immunity; CneF
Ag, Cryptococcus neoformans filtrate antigen; DTH, delayed type hyper-
sensitivity; IT, intratracheal inoculation; NBF, neutralbuffered formalin;
SDA, Sabouraud dextrose agar; SDB, Sabouraud dextrose broth.
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there is evidence that local and systemic immune responses
might differ afterpulmonary immunization (14). A previous
report involving this laboratory described a murine in-
tratracheal cryptococcal infection model and demonstrated
the critical role of CD4+ T cells in mediating systemic pro-
tection (5). However, the cryptococcal strain used in those
studies grew progressively in the lungs even in immunocompe-
tent mice. We have recently developed and characterized an-
other murine intratracheal cryptococcal infection model using
a less virulent strain of C. neofortnans in which pulmonary
clearance ofthe infection occurred in immunocompetent mice
but not in T cell-deficient mice (14a). Using this murine
model, we have addressed the question of whether CD4+
and CD8+ T cells had a positive, a negative, or no effect
on T cell-mediated pulmonary clearance.
Materials and Methods
Mice.
￿
BALB/c and C.B-17 mice were used throughout these
studies. BALB/c mice were obtained from Simonsen Laboratories,
Inc. (Gilroy, CA). C.B-17 (BALB/c strain congenic for C57BL6
IgH) were bred at The University of Texas Southwestern Medical
J. Exp. Med. C The Rockefeller University Press " 0022-1007/91/04/0793/08 $2.00
Volume 173 April 1991 793-800Center (Dallas, TX). Both male and female mice (8-12 wk) were
used, andthesexwas noted at necropsy. There wasno correlation
betweenthe sex of themice andyeast virulence. Mice were housed
in sterilized cages within apathogen-free environment tent. Steri-
lized food and water was given ad libitum. Mice were observed
for any overt signs of secondary infection and randomized mice
were tested at the conclusion of theexperiments and found to be
negative for serumantibodies to mousehepatitisvirus, Sendai virus,
and Mwoplasma pulmonis.
C. neoformans.
￿
C. neoformans 52D (15, 16) was used for these
studies. Strain 52D (24067; American Type Culture Collection,
Rockville, MD) is an encapsulated serotype D strain with an in
vitro generation time of 2.6 h. Stock cultures were grown on
Sabouraud dextrose agar (SDA; 1% neopeptone, 2% dextrose, 1%
agar) slants at room temperature and stored at -70°C. Working
cultures were prepared monthlyby thawing a stock culture and
inoculating fresh slants, and the working cultures were stored at
4°C. To prepare an infectinginoculum, yeast were inoculated from
a culture slant stored at 4°C into Sabouraud dextrose broth (SDB;
1% neopeptone, 2% dextrose) and grown on a shaker at room
temperature until confluent (36h). An aliquot of culture was col-
lected,washed threetimesin sterile nonpyrogenic saline (Travenol,
Deerfield, IL), counted on a hemocytometer, and diluted to the
appropriate concentration.
Route ofInfection.
￿
Mice were anesthetized with methoxyflurane
vapor (Metofane; Pitman-Moore, Washington Crossing, NJ), re-
strained on a smallboard, and infected with 10''5 CFU of C. neo
formans 52D in nonpyrogenic saline by surgical intratracheal in-
oculation (IT). A small incision was made through the skin over
the trachea. Theunderlying tissue was separatedand, using abent
30-gauge needle (BectonDickinson and Co., Rutherford, NJ) at-
tached by polyethylene tubing (Intramedic, Clay Adams, Parsip-
pany, NJ) to a tuberculin syringe (Monoject, St. Louis, MO), the
needle was inserted into and parallel with the trachea. A 50-,1 in-
oculum was then dispensed into the lungs. After inoculation, the
skin was sutured, and mice were allowed to recover. At periodic
intervals during the procedure, mice were over-anesthetized and
their lungs were removed to assay the number of CFU deposited
in the lungs.
AssayforOrgan CFU.
￿
At various time points infection, lungs,
brain, and spleen were removed, placed in a plastic sample bag
(Tekmar Co., Cincinnati, OH) filled with 2 ml sterile water, and
homogenized. Duplicates of 50 ji1 ofthehomogenate were plated
on SDA plates containing 50 p,g/ml chloramphenicol (Remel,
Lenexa, KS). Dilutions were made in sterile water as necessary.
Plates were incubated 3 d, and CFU expressed as logla CFU per
organ.
Delayed Type Hypersensitivity (DTH)Assay.
￿
Preparation ofcryp-
tococcal filtrate antigen (CneF Ag) wasadoptedfrom aprocedure
describedpreviously (17). Briefly, the supernatant, collected from
formaldehyde-treated cultures, was filtered through a0.45-/Am filter
(Corning Glass Works, Corning, NY) concentrated 50-fold in an
ultrafiltration unit (Amicon Corp., Danvers, MA) using a PM-30
membrane (Amicon Corp.), and dialyzed overnight against PBS.
The sample wasfilter sterilized, aliquotted, andstored at -20°C.
Protein concentration, as determined by Lowry assay (18), was
8 mg/ml. Control sample was prepared from uninoculated SDB
exactly as describedabove. Mice were challenged by footpadinjec-
tions of 30 pl of CneF Ag and 30 IA1 of control in the right and
left hind footpads, respectively, using a Tridak Stepper (Analytic
Lab Accessories, RockvilleCenter, NY)equipped with a30-gauge
needle and tuberculin syringe. Footpadthickness wasmeasured 48
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h later using amicrometer (Lux Scientific Instrument Corp., New
York, NY). The thicknessofthe right footpadminus theleft was
equal to swelling.
Preparation ofMonoclonal Antibodies.
￿
Therat mAbs, GK1.5 (anti-
CD4, 19)and YTS-169.4 (anti-CD8, 20), were raised as an ascites
in SCID mice primed with 0.5 ml pristane (2,6,10,14 Tetramethyl
Pentadecane; SigmaChemical Co., St.Louis, MO)intraperitoneally
1 wk before injection of cultured -10' hybridoma cells intra-
peritoneally. Ascites and normal rat serum (for control injections)
were purified on a protein A-Sepharose affinity chromatography
column (Bio-Rad Laboratories, Rockville Center, NY), dialyzed
against PBS, and protein concentration was measured by absor-
bance at 280 urn. The antibodies and control rat Ig were diluted
to 0.5 mg/ml in nonpyrogenic saline, filter sterilized, aliquotted,
and stored at -20°C.
Antibody-mediated In Vivo TCell Depletion.
￿
Mice were initially
given300,ug of mAbor control rat Ig as twointraperitonealinjec-
tions of 150 jug mAb or equal volume of sterile dialysate PBS (to
control for LPS contamination) on days -2 and 0 relative to the
day of infection. Depletion was maintained by repeated intra-
peritoneal injections of 100,ug mAb or control every 7-10 d after
the initial injections. Depletion was monitoredby staining spleen
and/or lung cells for CD4, CD8, and Thy-1.
Fluorescent Staining and Analysis.
￿
Aliquots of 106 spleens or
lung cells prepared as abovewere stainedby indirect immunofluores-
cence with 50 ul of one of the following stock antibodies diluted
in staining buffer (PBS, 0.1% NaN3, 1% FCS): GK1.5 (1:40),
YTS169.4 (1:40), isotype-matched rat IgG (1:40), 30H12 tissue
culture supernatant (1:10), or rat anti-mouse Ig (1:100; Jackson
Immunoresearch, Avondale, PA). The secondary antibody was
fluoresceinated F(ab')z mouse anti-rat IgG (1:40) (Jackson Im-
munoresearch) . Stained samples were analyzed on an Epics Profile
flow cytometer (Coulter Electronics Inc., Hialeah, FL) gating on
lymphocytes as judged from forward and side light scatter.
Cell Preparation.
￿
Spleen and/or lung lymphocyte cell suspen-
sions were prepared as follows. Spleens were removed and placed
inside sterile nylon mesh tubing (Bally Ribbon Mills, Bally, PA),
sealed at oneend, and thetubing was crushedwith arubber stopper
in RPMI to create a single cell suspension. Red blood cells were
lysed before washingcells for staining. Forlung lymphocytes, the
lungs and hilar nodes were removed, minced, and digested 60-90
minin digestionbuffer (RPMI, 10% FCS, antibiotics, 0.7 mg/ml
collagenase [Boehringer Mannheim Biochemicals, Indianapolis, IN]
and30 FAg/ml DNase [Sigma Chemical Co.]) . Thecell suspension
andundigested fragmentswere passed throughnylonmesh tubing,
furtherdissociated, washed, andpelletted, andredcells were lysed.
The sample was plated overnight at 37°C, 7% COZ in complete
media to remove adherent cells, and the nonadherent cells were
passed over a nylon wool column to further remove adherent cells
including most B cells.
Histopathology. Day 11-14 post-IT-infected mice were over-
anesthetized and their lungs inflated with 1 ml of 10% neutral
buffered formalin (NBF; 10% [vol/vol]37% formaldehyde in PBS)
fixed in NBF overnight, and hematoxylin- and eosin-stained sec-
tions were prepared.
Tissue samplesforimmunchistology from separate animalswere
snap frozen in 2-methyl butane (Kodak, Rochester, NY) in an ace-
tone/dry icebath. Frozen sections were stained using aVectorstain
ABC peroxidase kit (Vector Laboratories Inc., Burlingame, CA).
Sections were blocked 10 min with whole rabbit serum (Vector
Laboratories Inc.) PBS, and either hybridoma culture supernatant
or stock mAbdiluted, as describedabove, was used as theprimary
Immunity to Pulmonary Cryptococcosis Requires Both CD4' and CD8' T Cellsantibody. The secondary antibody was biotinylated rabbit anti-rat
Ig which had been absorbed with mouse Ig. A Nikon photomicro-
scope was used for photomicroscopy.
Statistics.
￿
Statistical significance was analyzed using the t test
with the significance level, p, modified for multiple comparisons
(the Bonferroni method for multivariance, reference 21).
Results
Effect ofIn Vivo T Cell Depletion on Pulmonary Clearance
and Extrapulmonary Dissemination of C. neoformans Strain
52D. Intratracheal inoculation of either BALB/c or C.B-17
mice with C. neoformans strain 52D resulted in a pulmonary
infection that was progressively cleared by a T cell-depen-
dent mechanism(s) beginning after anticryptococcal immu-
nity developed (between day 7 and 21 post-IT; reference 14a).
Flow cytometric analysis of the lymphocytes found in the
lungs of day 28, strain 52D-infected mice indicated that the
majority of the lymphocytes were larger, likely blast cells,
as expected for lymphocytes found at the site of infection
(data not shown) . Analysis of the blast cell population re-
vealed that both CD4+ and CD8+ T cells were present in
the infected lungs, at a ratio of ti3:1 (data not shown).
To analyze the influence of these two T cell subsets on
Table 1.
￿
Flow Cytometric Analysis of Lymphocyte-gated Spleen
Cellsfrom in Vivo T Cell-depleted Infected Mice
Pooled results from mice treated in parallel with mice analyzed in Figs. 2-4.
" Same as in Fig. 1.
t Percent positive after subtracting out background staining.
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pulmonary clearance and dissemination, groups ofmice treated
with control antibody or with mAb to deplete mice of
CD4+, CD8+, or both T cell subsets (22) were infected
with C. neoformans IT. At different time points during the
course ofthe experiment, splenic lymphocytes from infected
mice were analyzed to monitor T cell depletion (Table 1) and
revealed that the depletions were nearly complete in the face
ofinfection. An important observation was that CD4-depleted
mice had no CD4+ T cells in their lungs and CD8-depleted
mice had no CD8+ T cells, but infiltrating CD8+ T cell
influx still occurred in the absence of CD4+ T cells and vice
versa (Fig. 1). This suggested that CD4+ and CD8+ T cells
were recruited to the lungs by a mechanism independent of
the other T cell subset.
During the first 7 d of infection, the yeast grew progres-
sively in the lungs of all four groups of mice (Fig. 2). After
day 7, control mice began to clear the infection from their
lungs while pulmonary clearance failed to occur in CD4/CD8
double-depleted mice, consistent with the results obtained
usingSCID and nude mice (14a). In addition, neither CD4-
nor CD8-depleted mice cleared the infection from theirlungs,
demonstrating that both T cell subsets were required for effec-
tive immune pulmonary clearance.
Prevention of extrapulmonary dissemination and/or con-
trol of growth of the organism in the brain and spleen also
required both CD4+ and CD8+ T cells (Fig. 3). CD4-
depleted mice had significantly greater brain CFU at 21 and
35 d post-IT than control mice (Fig. 3 A and Table 2). At
day 35, CD8- and CD4/8-depleted mice also had significant
dissemination to the brain. In the spleen, dissemination oc-
c.~
ó
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Figure 1 .
￿
Quantitation of the CD4" and CD8+ infiltrating lung lym-
phocytes in infected, Tcell-depleted mice 21 d post-IT. Groups: control,
mice treated with sterile dialysate PBS; CD4 - , mice treated with mAb
GkI.5; Cß8 - , mice treated with mAb YTS169.4; CD4- /8- , mice
treated with both mAbs GK1.5 and YTS169.4. Data shown are from an
analysis of a pooled sample from five (control and CD4 - /8 -) or seven
(CD4 - and CD8-) mice for each group.
Group" Marker 1-2 wk 3-4 wk 5 wk
Control CD4 25.6# 25.5 23 .7
CD8 10.1 11.2 11 .3
Thy-1 37.7 51.8 50.1
Ig 38.4 48.0 46 .4
CD4- CD4 <i 4.2 <1
CD8 17.6 13.1 11 .4
Thy-1 18.4 16.1 15 .7
Ig 40.2 41.8 62.8
CD8- CD4 30.1 29.4 29 .2
CD8 4.9 2.6 4.9
Thy-1 35.5 31 .0 46.0
Ig 40.4 32.5 38.5
CD4-/8 - CD4 1.2 4.0 4.1
CD8 <1 <1 2.4
Thy-1 4.0 2.7 7.4
Ig 29.1 57.3 65.8Days Post-IT Inoculation
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Figure 2.
￿
Pulmonary clearance ofC . neoformans 52D in control and T
cell-depleted mice . Thegroups are the same as in Fig. 1 . Error bars have
been omitted for clarity. CFUwere detected in all animals studied. Statistics:
(*)p<0.008 compared with control group. n (mice/time pt .) = con-
trol, 17; CD4-, 10 ; CD8 - , 10; CD4/8 - , 10 . Data are pooled from two
experiments .
curred by day 21 in nearly all mice including controls (Fig.
3B and Table 2) . However, while the control mice had begun
to clear the yeast from their spleens by day 35, the CD4-,
CD8-, and CD4/8-depleted mice continued to harbor low
levels of organisms in their spleens.
Role ofT Cells In Anticryptococcal DTH
￿
T cell-depleted
infected mice were challenged for anticryptococcal DTH 7,
21, and 35 d post-IT (Fig. 4) . DTH was detectable in control
and C138-depleted mice but not in CD4- or CD4/8-depleted
mice. These results are consistent with previous reports demon-
strating that CD4+ T cells mediate anticryptococcal DTH
(2-5) .
Histology ofthe Cryptococcal Infection inBALM Mice .
￿
To
further examine the effects of CD4 and CD8 depletion on
the inflammatory process occurring in the lungs, lungs from
IT mice from parallel or similar experiments as previously
described were histologically examined 11-14 d post-IT
In control mice (CD4+8 + ), there was a large inflamma-
tory influx into the lungs involving approximately half of
the alveoli, and perivascular leukocytic cuffing was promi-
nent (Fig. 5 A) . The predominant cells in the alveolar influx
were macrophages, but neutrophils and lymphocytes were
also present . Most cryptococci were in focal clusters enclosed
in capsular material . This histologic picture in the lungs of
B 4
3~
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Days Post-IT
Figure 3. Dissemination of C . neoformans 52D in control and T
cell-depleted mice . The groups are the same as in Fig . 1 . Error bars were
omitted for clarity. (A) Brain CFU ; (B) spleen CFU . Organs without
detectable CFUwere included in the analysis as logloCFU = 0 . Statistics :
(*) p < 0.008 compared with control group, (+) p < 0.008 compared
with CD8- group. Data are pooled from three experiments .
cryptococcal-infected mice has also been described by others
(23, 24) . Some single, encapsulated yeast were observed within
macrophages in the lungs . Overall, relatively few cryptococci
were present compared to thenumber ofinflammatory cells .
Figure 4.
￿
DTH to CneF Ag in C, neoformans 52D-infected, T cell-
depleted mice . The groups are the same as in Fig . 1 . Bars indicate the
SD. The footpad swelling ofuninfected, naivemicechallenged with CneF
Ag is shown as a dotted line. Statistics : (*) p < 0.008 compared with
both control and CD8- at the same time point . n = 7-25 mice/time
pt . Data are pooled from three experiments .
Data represent the number of mice with detectable CFU in the brain or spleen over the total number of mice examined at that time point .
Table 2 . Incidence of
Control
Dissemination of
CD4-
C. neoformans 52D
Brain
CD8-
in Control and
CD4- /8-
T Cell-depleted
Control
Mice
CD4 -
Spleen
CD8 - CD4- /8-
Day 7
Day 21
Day 35
3/17
4/22
1/17
2/10
11/18
6/10
2/10
4/17
6/10
2/10
5/15
6/10
7/17
19/22
7/17
6/10
18/18
7/10
7/10
13/17
7/10
6/10
11/15
6/10Immunohistochemistry of the lungs revealed CD4+ and
CD8+ T cells scattered throughout the inflammatory exu-
dates (data not shown), with CD4+ T cells outnumbering
CD8+, consistent with the 3:1 ratio of CD4+ to CD8+ T
cells found by flow cytometry (data not shown) .
Inflammatory cells were sparse in the lungs of CD4/8
double-depleted mice (CD4 - 8 - ) (Fig . 5 B) . An occasional
small focus of macrophages was observed, but as expected,
a lymphocytic influx was absent and little or no perivascular
cuffing occurred . Large masses of cryptococci filled many of
the airspaces .
In CD4-depleted mice (CD4- 8+), inflammation was in-
termediate between that seen in the lungs of the control and
double-depleted mice (data not shown). Macrophages, neu-
trophils, and lymphocytes were present in the inflamed tissue,
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Figure 5 . Photomicrograph of the lungs
from C. neofortnans 52D-infected, T cell-
depleted mice 11-14 d post-IT (A) Control,
(B) CD4/8-depleted (x 200), hemotoxylin and
eosin . The alveoli in B appear larger because
they have been distended by the cryptococcal
polysaccharide .
and perivascular cuff's were also observed. There were large
masses ofencapsulated yeast throughout the lungs with few
inflammatory cells inside the cryptococcal masses. Immuno-
histochemistry confirmed the depletion of CD4+ T cells
while CD8+ T cells were scattered throughout the tissue
often adjacent to masses of cryptococci (data not shown) .
Similar to CD4-depleted mice, the inflammatory response
in the lungs of CD8-depleted mice (CD4+8 - ) was inter-
mediate between control and double-depleted mice and con-
sisted of macrophages, neutrophils, and lymphocytes (data
not shown) . Pbrivascular cuffing occurred, but the major differ-
ence between the two groups of single T cell-depleted mice
was the distribution of cryptococci in the tissue . Numerous
organisms were present and many appeared to be encapsu-
lated single cells engulfed by macrophages . As expected, im-munohistochemistry demonstrated numerous, CD4+ with
only a rare CD8+ T cell in the inflammatory influx (data
not shown).
Discussion
There are three major observations in the current study.
First, both CD4+ and CD8+ T cells were important in the
clearance of the pulmonary infection caused by intratracheally
administered C. neoformans 52D. Second, histologic studies
demonstrated that at the time clearance was occurring, the
maximal influx ofnonlymphoid inflammatory cells accumu-
lated only in animals that contained both CD4+ and CD8+
T cells. Third, both CD4+ and CD8+ T cells played a role
in the degree of infection detected in extrapulmonary tissues,
i.e., spleen and brain. In regard to this last point, prevention
of dissemination and dissemination could not be distinguished
in these experiments. The assay, brain or spleen CFU, is a
measure of the sum of these two processes. However, since
splenic dissemination occurred even in control animals but
was then cleared, it seems likely that extrapulmonary T
cell-mediated defenses function in our model to clear the yeast
from the extrapulmonary organ after dissemination has oc-
curred.
An important observation was that both CD4+ and
CD8+ T cells were required for effective pulmonary clear-
ance. Mody et al. (5) did not see evidence of CD4+ T cell
involvement in pulmonary clearance afterintratracheal inocu-
lation. However, the strain of C. neoformans used in those
studies (145A) grows progressively even in the lungs of im-
munocompetent mice and ultimately results in a fataldisease
(5, 25, 26). The effect ofCD4 depletion was to decrease sys-
temic clearance and survival in an already fatal infection model
(5) . The major difference between the 145A and the 52D
cryptococcal infection models is that a 52D infection is resolved
in immunocompetent mice (14a). Thus, the 52D strain is
clearly a more relevant strain to use for studying defense mech-
anisms during opportunistic pulmonary infections.
Another important observation is that CD8+ T cells are
necessary for clearance of a C. neoformans 52D pulmonary
infection. Although proliferation of human CD8+ T cells
has been observed in vitro after culturing PBLs, with heat-
killed cryptococci (27), CD8+ T cells have not been docu-
mented to be involved in protective anticryptococcal CMI.
There are two likely mechanisms for CD8+ T cell-mediated
protection.
First, CD8+ T cells might be involved in recruiting
effector cells to the site of infection. The nonlymphocytic
cellular infiltrate in the lungs of single subset-depleted animals
was intermediate between that seen in control and CD4/8
double-depleted animals. In lymphocytic choriomeningitis
virus-infected mice, activated CD8+ T cells alone can me-
diate a DTH reaction by recruiting monocyte/macrophages,
other activated or "resting" CD8+ T cells, but not CD4+
T cellsinto the cerebrospinal fluidof infected mice (28). The
secreted cytokine profile of activated CD8+ T cells is very
similar to the profile of CD4+ Th1 cells, the classic medi-
ators of DTH. Both of these T cell types can secrete IFN-.y,
GM-CSF, IL3, TNF-ci, and TNF-S, although CD4+ T
cells produce higher levels of these cytokines after in vitro
stimulation (29, 30).
Second, CD8+ T cells may lyse unactivated macrophages
containing phagocytized cryptococdallowing activated effector
cells to phagocytize and kill the yeast. Macrophages from
many tissue sources, including alveolar macrophages, can
phagocytize C. neoformans in vitro (31-34). However, once
the yeast is engulfed it may not be killed unless the macro-
phage has previously been activated (35, 36). In one in vivo
study, murine liver macrophages initially ingested cryptococci
injected intravenously, but did not kill the engulfed yeast (37).
A granulomatous reaction developed at the time cryptococci
were eliminated. This response did not occurin nude mice,
rather, a cystic lesion full of organisms developed. Some reports
suggest that C. neoformans can replicate within unactivated
macrophages (31, 33); others dispute this notion (32).
Nevertheless, encapsulated cryptococci can survive inside
phagocytes (31-36) potentially protected from other crypto-
cidal phagocytes, e.g., activated macrophages and neutrophils.
Circumstantial evidence for a macrophage lytic role for
CD8+ T cells relates to the histologic sections. In infected
CD4+8 - mice, a large number of apparently engulfed-but-
intact encapsulated cryptococci were observed in tissue sec-
tions of the lungs (data not shown). In contrast, only a few
engulfed encapsulated yeast were seen in lung sections from
CD4+8+ mice and almost none were seen in CD4-8+
mice. A scenario that could account for the differencein phago-
cytosis from the different groups of infected, T cell-manipu-
lated mice is that CD4+ T cells activate phagocytic macro-
phages for cryptocidal activity while CD8+ T cells lyse
unactivated phagocytes that have taken up yeast but cannot
kill them, thus releasing organisms to be engulfed and killed
by activated phagocytes.
Similar phagocyte lysis models have been proposed for in-
fections by other microorganisms including listeria and
mycobacteria (38). The common feature of these latter two
infectionsis that both bacteria are facultative intracellular para-
sites of macrophages. Ag-specific, MHC-restricted, and non-
restricted CD8+ T cells that are cytolytic for mycobacteria-
exposed macrophages are generated during a mycobacterial
infection (39, 40). Similarly, CD8+ cytolytic T cells specific
for listeria-infected macrophages can also be isolated from
listeria-infected mice (41-43) . In several studies of listeria-
infected mice, CD8± T cells were totally responsible for pro-
tective immunity (44-48). In one study, adoptive transfer of
listeria-immune splenic T cell subsets demonstrated that in
mice given CD4+ T cells, phagocytes accumulated at the
sites of infection but the mice could not resolve the infec-
tion. In listeria-infected mice who received CD8+ T cells,
phagocytes did not accumulate but they resolved the infec-
tion. These studies suggest that CD8+ T cells depleted
phagocytes that harbored but did not kill the bacteria (44).
During a cryptococcal infection, therefore, CD8+ T cells
may have two roles in protective immunity: first, to lyse
cryptococcus-laden phagocytes, and second, to recruit resi-
dent phagocytes to the site of infection. However, CD4+ T
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tive to CD8+ T cells, may be more effective at recruiting
and activating effector phagocytes from the circulation. As
a result of these synergistic interactions, both CD4' and
CD8+ T cells would be necessary for pulmonary immunity.
Further experiments will determine whether CD8+ T cells
have cytotoxic activity as proposed in this model.
In terms of relevance to cryptococcosis in humans, it is
interesting to note that pulmonary cryptococcosis is rare in
patients with AIDS. CD8 levels are normal or even elevated
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